RedHill Biopharma Ltd. , an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs for the treatment of inflammatory and gastrointestinal diseases and related conditions, including cancer, today reported that the Japan Patent Office has issued a Decision to Grant a ... (more)
More...
More...